Advertisement

Registries

  • Steffen BülowEmail author
  • Inge Bernstein
Chapter
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 5)

Abstract

Familial Cancer Registries have proven to be invaluable in identifying individuals at risk of hereditary colorectal cancer syndromes and their families. With the advent of registries, call-up patients shown to have better survival than index patients. In this chapter, the establishment, purpose, and function of familial cancer registries will be discussed.

Keywords

Familial adenomatous polyposis Hereditary non-polyposis colorectal cancer Lynch syndrome Hereditary colorectal cancer Registry National registration 

References

  1. 1.
    Lockhart-Mummery JP. Familial adenomatosis of colon and rectum. Its relationship to cancer. Lancet. 1939;2:586–9.CrossRefGoogle Scholar
  2. 2.
    Alm T, Licznerski G. The intestinal polyposes. Clin Gastroenterol. 1973;2:577–602.Google Scholar
  3. 3.
    Bülow S, Sprechler M. A polyposis registry. Ugeskr Laeger. 1980;142:1839–40.Google Scholar
  4. 4.
    Gedde-Dahl Jr T, Heim S, Lothe R, Bye R, Geitvik GA, Kyrkjebo HT, et al. The polyposis project. Nord Med. 1989;104:12–5.PubMedGoogle Scholar
  5. 5.
    Järvinen HJ, Husa A, Aukee S, Laitinen S, Matikainen M, Havia T. Finnish registry for familial adenomatosis coli. Scand J Gastroenterol. 1984;19:941–6.PubMedGoogle Scholar
  6. 6.
    Vasen HF, Griffioen G, Offerhaus GJ, Den Hartog Jager FC, Van Leeuwen-Cornelisse IS, Meera Khan P, et al. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands. Dis Colon Rectum. 1990;33:227–30.CrossRefPubMedGoogle Scholar
  7. 7.
    F.A.P.A. Statuts de la Familial Adenomatous Polyposis Association. A.S.B.I. Moniteur Belge. 1993;14219:6377–80.Google Scholar
  8. 8.
    Samalavicius NE, Drasutis RK, Buineviciute A, Kirtiklis A, Kucinskas V, Avizienyte E, et al. Familial adenomatous polyposis: first report of the Lithuanian Register. Acta Med Lituanica. 1996;2:39–46.Google Scholar
  9. 9.
    Filipitsch T, Wolf B, Karner-Hanusch J. Results of molecular diagnosis in 30 Austrian families with familial adenomatous polyposis. Wirn Klin Wochenschr. 2001;113:446–50.Google Scholar
  10. 10.
    Kadiian K, Stoinov S, Penchev P, Mikhova A, Damianov D, Aleksandrova A, et al. Polyposis of the colon and cancer. Khirurgiia (Sofiia). 2004;60:42–4.Google Scholar
  11. 11.
    Kohoutova M, Stekrova J, Sulova M, Zidkova K, Kleibi Z, Vandrovcova J, et al. Hereditary forms of colorectal adenomatous polyposis. Cas Lék Cesk. 2006;145:475–9.PubMedGoogle Scholar
  12. 12.
    Hadjisavvas A, Papasavva T, Loizidou M, Malas S, Potamitis G, Christodoulou C, et al. Novel germline mutations in the APC gene of Cypriot patients with familial and sporadic adenomatous polyposis. Clin Genet. 2006;69:404–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Myrhøj T, Bernstein IT, Bisgaard ML, Svendsen LB, Søndergaard JO, Mohr J, et al. The establishment of an HNPCC Register. Anticancer Res. 1994;14:1647–50.PubMedGoogle Scholar
  14. 14.
    Möslein G, Buhr HJ, Kadmon M, Herfarth C. Familial adenomatous polyposis. Initial experiences with the Heidelberg polyposis register. Chirurg. 1992;63:327–33.PubMedGoogle Scholar
  15. 15.
    Mandl M, Paffenholz R, Friedl W, Caspari R, Sengteller M, Propping P. Frequency of common and novel inactivating APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet. 1994;3:181–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Czeizel E, Ritter L. Registration of patients with colonic polyposis in Hungary. Orv Hetil. 1987;128:913.PubMedGoogle Scholar
  17. 17.
    Ponz de Leon M, Sassatelli R, Zanghieri G, Sacchetti C, Roncucci L, Scalmatai A, et al. Hereditary adenomatosis of the colon and rectum: clinical features of eight families from Northern Italy. Am J Gastroenterol. 1989;84:906–16.PubMedGoogle Scholar
  18. 18.
    Pietroiusti M, Bertario L, Annabali R, Sichel L. The registry of familial colonic polyposis and its implementation. Minerva Chir. 1989;44:1873–4.PubMedGoogle Scholar
  19. 19.
    Plawski A, Lubinski J, Banasiewicz T, Paszkowski J, Lipinski D, Strembalska A, et al. Novel germline mutations in the adenomatous polyposis gene in Polish families with familial adenomatous polyposis. J Med Genet. 2004;41:e11.CrossRefPubMedGoogle Scholar
  20. 20.
    Fidalgo PO, Maia LC, Cravo ML, Albuquerque CM, Suspiro A, Ramalho E, et al. Seven novel mutations in the APC gene of Portuguese families with familial adenomatous polyposis: correlation with phenotype. Cancer Genet Cytogenet. 1999;111:152–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Isidro G, Matos P, Almeida S, Claudino S, Marshall B, Soares J, et al. Eleven novel APC mutations identified in Portuguese FAP families. Hum Mutat. 2000;16:178.CrossRefPubMedGoogle Scholar
  22. 22.
    Nikitin AM, Obukov VK, Chubarov YY, Jakushin AV. Results of a thirty-year study of familial adenomatous polyposis coli. Dis Colon Rectum. 1997;40:679–84.CrossRefPubMedGoogle Scholar
  23. 23.
    Reyes Moreno J, Ginard Vicens D, Vanrell M, Marinó Z, Garau I, Llompart A, et al. Impact of a registry on survival familial adenomatous polyposis. Med Clin (Barc). 2007;129(2):51–2.CrossRefGoogle Scholar
  24. 24.
    Lockhart-Mummery JP. Cancer and heredity. Lancet. 1925;1:427–9.CrossRefGoogle Scholar
  25. 25.
    Phillips RKS, Spigelman AD, Thomson JPS, editors. Familial adenomatous polyposis and other polyposis syndromes. London: Edward Arnold; 1994.Google Scholar
  26. 26.
    Burn J, Chapman P, Delhanty J, Wood C, Lalloo F, Cachon-Gonzalez MB, et al. The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet. 1991;28:289–96.CrossRefPubMedGoogle Scholar
  27. 27.
    Campbell WJ. Regional register for familial adenomatous polyposis. Br J Surg. 1991;78:1511.CrossRefPubMedGoogle Scholar
  28. 28.
    Morton DG, Macdonald F, Haydon J, Cullen R, Barker G, Hulten M, et al. Screening practice for familial adenomatous polyposis: the potential for regional registers. Br J Surg. 1993;80:255–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003;362:39–41.CrossRefPubMedGoogle Scholar
  30. 30.
    Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer registries in the United States. Dis Colon Rectum. 2004;47:674–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Aquino A, Garcia C, Dosluoglu H, Frelick R, Johnstone EA, Lebowitz HA, et al. Familial adenomatous polyposis in Delaware. Del Med J. 1993;65:627–44.PubMedGoogle Scholar
  32. 32.
    Petersen GM. Genetic testing and counseling in familial adenomatous polyposis. Oncology. 1996;10:89–94.PubMedGoogle Scholar
  33. 33.
    Sener SF, Miller HH, DeCosse JJ. The spectrum of polyposis. Surg Gynecol Obstet. 1984;159:525–32.PubMedGoogle Scholar
  34. 34.
    Gingold BS, Jagelman D, Turnbull RB. Surgical management of familial polyposis and Gardner’s syndrome. Am J Surg. 1979;137:54–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Kulling D, Green J, Pai GS, Baron PL, Baker SS, Lewin D, et al. Familial adenomatous polyposis registry in South Carolina. J S C Med Assoc. 1997;93:405–9.PubMedGoogle Scholar
  36. 36.
    Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA, et al. Genetic testing in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology. 2004;127:444–51.CrossRefPubMedGoogle Scholar
  37. 37.
    Berk T, Cohen Z, McLeod RS, Cullen JB. Surgery based on misdiagnosis of adenomatous polyposis. The Canadian Polyposis Registry experience. Dis Colon Rectum. 1987;30:588–90.CrossRefPubMedGoogle Scholar
  38. 38.
    Cruz-Bustillo D, Villasana L, Llorente F, Casadesus D, Garcia E, Syrris P, et al. Preliminary results of the molecular diagnosis of familial adenomatous polyposis in Cuban families. Int J Colorectal Dis. 2002;17:344–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Soto G, Lopez-Kostner F, Zarate A, Vuletin F, Rahmer A, Leon F, et al. Treatment of familial adenomatous polyposis and family screening. Rev Med Chil. 2005;133:1043–50.PubMedGoogle Scholar
  40. 40.
    Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, Toshihiko Nakagawa W, Aguilar Jr S, Monteiro Santos EM, et al. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer. 2004;3:41–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Aitken RJ, Elliot MS, Torrington M, Louw JH. Twenty years experience with familial polyposis coli in Cape Town. Br J Surg. 1986;73:210–3.CrossRefPubMedGoogle Scholar
  42. 42.
    Rozen P, Samuel Z, Rabau M, Goldman G, Shomrat R, Legum C, et al. Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features. Fam Cancer. 2001;1:75–82.CrossRefPubMedGoogle Scholar
  43. 43.
    Utsunomiya J. Present status of adenomatosis coli in Japan. In: Farber E et al., editors. Pathophysiology of carcinogenesis in digestive organs. Tokyo: University of Tokyo Press; 1977. p. 305–21.Google Scholar
  44. 44.
    Iwama T, Tamura K, Morita T, Hirai T, Hasegawa H, Koizumi K, et al. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol. 2004;9:308–16.CrossRefPubMedGoogle Scholar
  45. 45.
    Park JG, Park KJ, Ahn YO, Song IS, Choi KW, Moon HY, et al. Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum. 1992;35:996–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Goh HS, Wong J. The Singapore Polyposis Registry. Ann Acad Med Singapore. 1992;21:290–3.PubMedGoogle Scholar
  47. 47.
    Ho JW, Chu KM, Tse CW, Yuen ST. Phenotype and management of patients with familial adenomatous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. Hong Kong Med J. 2002;8:342–7.PubMedGoogle Scholar
  48. 48.
    He YL, Zhang CH, Huang MJ, Cai SR, Zhan WH, Wang JP, et al. Clinical analysis of eight kindreds of familial adenomatous polyposis. World J Gastroenterol. 2004;10:3659–61.PubMedGoogle Scholar
  49. 49.
    Li Y, Song S, Jiang Y. Diagnosis and treatment of familial adenomatous polyposis. Zhonghua Wai Ke Za Zhi. 1999;37:328–30.PubMedGoogle Scholar
  50. 50.
    Bower C, Levitt S, Francis S. The Western Australian Familial Polyposis Registry. Med J Aust. 1989;151:557–8.PubMedGoogle Scholar
  51. 51.
    Macrae FA, St. John DJ, Muir EP, Penfold JC, Cuthbertson AM. Impact of a hospital-based register on the management of familial adenomatous polyposis. Med J Aust. 1989;151:552–7.PubMedGoogle Scholar
  52. 52.
    Weir L, Spigelman A, Scott R, Kirk J, Zeckendorf S, Sitas F. The NSW & ACT Hereditary Cancer Registers. Aust Fam Physician. 2005;34:53–8.PubMedGoogle Scholar
  53. 53.
    James P, Parry S, Arnold J, Winship I. Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand. N Z Med J. 2006;119:U2168.PubMedGoogle Scholar
  54. 54.
    Warthin AS. Heredity with reference to carcinoma as shown by the study of the cases examinated in pathological laboratory of the University of Michigan. Arch Intern Med. 1913;12:546–55.CrossRefGoogle Scholar
  55. 55.
    Lynch HT, Krush AJ. Cancer family “G” revisited: 1895–1970. Cancer. 1971;27(6):1505–11.CrossRefPubMedGoogle Scholar
  56. 56.
    Lynch HT, Lynch PM, Albano WA, Lynch JF. The cancer family syndrome: a status report. Dis Colon Rectum. 1981;24(4):311–22.PubMedGoogle Scholar
  57. 57.
    Mecklin JP, Sipponen P, Järvinen HJ. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum. 1986;29(12):849–53.CrossRefPubMedGoogle Scholar
  58. 58.
    Vasen HF, den Hartog Jager FC, Menko FH, Nagengast FM. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindred in the Netherlands. Am J Med. 1989;86(3):278–81.CrossRefPubMedGoogle Scholar
  59. 59.
    Bülow S, Burn J, Neale K, Northover J, Vasen H. The establishment of a polyposis register. Int J Colorectal Dis. 1993;8:34–8.CrossRefPubMedGoogle Scholar
  60. 60.
    Church JM, McGannon E. A polyposis registry: how to set one up and make it work. Semin Colon Rectal Surg. 1995;6:48–54.Google Scholar
  61. 61.
    Tupasela A. When legal worlds collide: from research to treatment in hereditary cancer prevention. Eur J Cancer Care. 2006;15:257–66.CrossRefGoogle Scholar
  62. 62.
    Council of Europe. Directive 95/46/EC on the protection and the free movement of such data. http://europa.eu.int (1995). Retrieved 6 Sept 2004.
  63. 63.
    Fears R, Poste G. Building population genetics resources using the UK NHS. Science. 1999;284:267–8.CrossRefPubMedGoogle Scholar
  64. 64.
    Fletcher A. Fields of genes: the politics of science and identity in the Estonian genomic project. New Genet Soc. 2004;23:3–14.CrossRefPubMedGoogle Scholar
  65. 65.
    Kaye J, Helgason HH, Nomper A, Sild T, Wendel L. Population genetic databases: a comparative analysis of the laws in Iceland, Sweden, Estonia and the UK. Trames. 2004;8:15–33.Google Scholar
  66. 66.
    Koch L, Svendsen NM. Providing solutions – defining problems. The imperative of disease prevention in genetic counselling. Soc Sci Med. 2005;60:823–32.CrossRefPubMedGoogle Scholar
  67. 67.
    Offit K, Groeger E, Turner S, Wadsworth EA, Weiser M. The “Duty to Warn” a patient’s family members about hereditary disease risk. J Am Med Assoc. 2004;292:1469–73.CrossRefGoogle Scholar
  68. 68.
    Björk J, Åkerbrant H, Iselius L, Alm T, Hultcrantz R. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females. Scand J Gastroenterol. 1999;34:1230–5.CrossRefPubMedGoogle Scholar
  69. 69.
    Bülow S. Results of national registration of familial adenomatous polyposis. Gut. 2003;52:742–6.CrossRefPubMedGoogle Scholar
  70. 70.
    Järvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut. 1992;33:357–60.CrossRefPubMedGoogle Scholar
  71. 71.
    Vasen HF, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, et al. Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer. 1995;31A:1145–8.CrossRefPubMedGoogle Scholar
  72. 72.
    Järvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405–11.CrossRefPubMedGoogle Scholar
  73. 73.
    Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829–34.CrossRefPubMedGoogle Scholar
  74. 74.
    Arrigoni A, Sprujevnik T, Alvisi V, Rossi A, Ricci G, Pennazio M, et al. Clinical identification and long-term surveillance of 22 hereditary non-polyposis colon cancer Italian families. Eur J Gastroenterol Hepatol. 2005;17:213–9.CrossRefPubMedGoogle Scholar
  75. 75.
    de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, Menko FH, Taal BG, Kleibeuker JH, et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum. 2002;45:1588–94.CrossRefPubMedGoogle Scholar
  76. 76.
    Stormorken AT, Clark N, Grindedal E, Maehle L, Moller P. Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer. Scand J Gastroenterol. 2007;42(5):611–7.CrossRefPubMedGoogle Scholar
  77. 77.
    Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293:1979–85.CrossRefPubMedGoogle Scholar
  78. 78.
    Dove-Edwin I, Sasieni P, Adams J, Thomas H. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005;331:1047.CrossRefPubMedGoogle Scholar
  79. 79.
    Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology. 2006;130:1995–2000.CrossRefPubMedGoogle Scholar
  80. 80.
    Myrhøj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bülow S. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol. 1997;32:572–6.CrossRefPubMedGoogle Scholar
  81. 81.
  82. 82.
    Heiskanen I, Luostarinen T, Järvinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol. 2000;35:1284–7.CrossRefPubMedGoogle Scholar
  83. 83.
    Bussey HJR. Familial polyposis coli. Family studies, histopathology, differential diagnosis and results of treatment. Baltimore, MD: The Johns Hopkins University Press; 1975.Google Scholar
  84. 84.
    Penna CP, Tiret E, Kattheuser AH, Olschwang S, Parc R. Value of screening of familial adenomatous polyposis for the prevention of colorectal cancer. Gastroentérol Clin Biol. 1992;16:210–4.PubMedGoogle Scholar
  85. 85.
    Bertario L, Presciuttini S, Sala P, Rossetti C, Pietroiusti M. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. Semin Surg Oncol. 1994;10:225–34.CrossRefPubMedGoogle Scholar
  86. 86.
    Galle TS, Juel K, Bülow S. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol. 1999;34:808–12.CrossRefPubMedGoogle Scholar
  87. 87.
    Belchetz LA, Berk T, Bapat BV, Cohen Z, Gallinger S. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1996;39:384–7.CrossRefPubMedGoogle Scholar
  88. 88.
    Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1990;33:639–42.CrossRefPubMedGoogle Scholar
  89. 89.
    Bertario L, Russo A, Sala P, Eboli M, Radice P, Presciuttini S, et al. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer. 1999;80:183–7.CrossRefPubMedGoogle Scholar
  90. 90.
    de Jong AE, Morreau H, van Puijenbroek M, Eilers PH, Wijnen J, Nagengast FM, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology. 2004;126:42–8.CrossRefPubMedGoogle Scholar
  91. 91.
    Mecklin JP, Jarvinen HJ, Aukee S, Elomaa I, Karjalainen K. Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol. 1987;22:449–53.CrossRefPubMedGoogle Scholar
  92. 92.
    Vasen HF. FC, Menko FH, Nagengast FM. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am J Med. 1989;86:278–81.CrossRefPubMedGoogle Scholar
  93. 93.
    Rodríguez-Bigas MA, Lee PH, O’Malley L, Weber TK, Suh O, Anderson GR, et al. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum. 1996;39(6):649–53.CrossRefPubMedGoogle Scholar
  94. 94.
    Renkonen-Sinisalo L, Aarnio M, Mecklin JP, Jarvinen HJ. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev. 2000;24:137–42.PubMedGoogle Scholar
  95. 95.
    de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, et al. Shift in mortality due to surveillance in the Lynch syndrome. Gastroenterology. 2006;130:665–71.CrossRefPubMedGoogle Scholar
  96. 96.
    de Jong AE, Nagengast FM, Kleibeuker JH, van de Meeberg PC, van Wijk HJ, Cats A, et al. What is the appropriate screening protocol in Lynch syndrome? Fam Cancer. 2006;5:373–8.CrossRefPubMedGoogle Scholar
  97. 97.
    James P, Parrry S, Arnold J, Winship I. Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand. N Z Med J. 2006;119:1242.Google Scholar
  98. 98.
    Tanyi M, Kanyári Z, Orosz L, Juhász B, Lukács G, Damjanovich L. Clinical significance of HNPCC, surgical aspects of early recognition. Magy Seb. 2004;57:267–78.PubMedGoogle Scholar
  99. 99.
    Rose PW, Murphy M, Munafo F, Chapman C, Mortensen N, Lucassen A. Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study. Br J Gen Pract. 2004;54:267–71.PubMedGoogle Scholar
  100. 100.
    Aaltonen LA, Sankila R, Mecklin JP, Järvinen H, Pukkala E, Peltomäki P, et al. A novel approach to estimate the proportion of hereditary non-polyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prec. 1994;18:57–63.Google Scholar
  101. 101.
    Liu SR, Zhao B, Wang ZJ, Wan YL, Huang YT. Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary non-polyposis colorectal carcinoma. World J Gastroenterol. 2004;10:2647–51.PubMedGoogle Scholar
  102. 102.
    Nakahara M, Yokozaki H, Yasui W, Dohi K, Tahara E. Identification of concurrent germ-line mutations I hMSH2 and or hMLH1 in Japanese hereditary non-polyposis colorectal cancer kindreds. Cancer Epidemiol Biomarkers Prev. 1997;6:1057–64.PubMedGoogle Scholar
  103. 103.
    Wang Q, Lasset C, Desseigne F, Saurin JC, Maugard C, Navarro C, et al. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with non-polyposis colorectal cancer. Hum Genet. 1999;105:79–85.CrossRefPubMedGoogle Scholar
  104. 104.
    Bai YQ, Akiyama Y, Nagasaki H, Lu SL, Arai T, Morisaki T, et al. Predominant germline mutation of the hMSH2 gene in Japanese hereditary non-polyposis colorectal cancer kindreds. Int J Cancer. 1999;82:512–5.CrossRefPubMedGoogle Scholar
  105. 105.
    Ponz de Leon M, Sassatelli R, Benatti P, Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry. Cancer. 1993;71:3493–501.CrossRefPubMedGoogle Scholar
  106. 106.
    Wolf B, Gruber S, Henglmueller S, Kappel S, Bermann M, Wrba F, et al. Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer. 2006;118:1465–70.CrossRefPubMedGoogle Scholar
  107. 107.
    Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, et al. Ontario familial colon Cancer registry: methods and first-year response rates. Chronic Dis Can. 2000;21:81–6.PubMedGoogle Scholar
  108. 108.
    Kohut K, Manno M, Gallinger S, Esplen MJ. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry. J Med Genet. 2007;44:404–7.CrossRefPubMedGoogle Scholar
  109. 109.
    Reyes J, Ginard D, Barranco L, Escarda A, Vanrell M, Mariño Z, et al. Implantation of a hospital registry of hereditary nonpolyposis colorectal cancer. Gastroenterol Hepatol. 2006;29:437–42.CrossRefPubMedGoogle Scholar
  110. 110.
    Elsakov P, Kurtinaitis J. Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania-initial results. Fam Cancer. 2006;5:369–71.CrossRefPubMedGoogle Scholar
  111. 111.
    Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, et al. After hMSH2 and h MLH1 – what next? Analysis of three-generational, population-based, early-onset colorectal cancer families. Int J Cancer. 2002;102:166–71.CrossRefPubMedGoogle Scholar
  112. 112.
    Hemminki K, Li X. Familial colorectal adenocarcinoma from the Swedish Family-Cancer Database. Int J Cancer. 2001;94:743–8.CrossRefPubMedGoogle Scholar
  113. 113.
    Mosquera RA, Lynch HT. Hereditary colorectal carcinoma syndromes and their implications for colorectal carcinoma in Puerto Rico. Bol Asoc Med P R. 1998;90:140–3.PubMedGoogle Scholar
  114. 114.
    Lynch P, Winn RJ. Clinical management of hereditary nonpolyposis colon cancer. High-risk clinics and registries. Hematol Oncol Clin North Am. 1989;3:75–86.PubMedGoogle Scholar
  115. 115.
    Mangold E, Pagenstecher C, Friedl W, Mathiak M, Buettner R, Engel C, et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer. 2005;116:692–702.CrossRefPubMedGoogle Scholar
  116. 116.
    Goecke T, Schulmann K, Engel C, Holinski-Feder E, Pagenstecher C, Schackert HK, et al. German HNPCC Consortium. J Clin Oncol. 2006;24:4285–92.CrossRefPubMedGoogle Scholar
  117. 117.
    Jablonská M, Rezníková L, Kotrlík J, Svitavský M, Miková M, Tabach J. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer. Sb Lek. 1995;96:275–82.PubMedGoogle Scholar
  118. 118.
    Parc Y, Boisson C, Thomas G, Olschwang S. Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet. 2003;40:208–13.CrossRefPubMedGoogle Scholar
  119. 119.
    Bertario L, Russo A, Sala P, Eboli M, Radici P, Presciuttini S, et al. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer. 1999;80:183–7.CrossRefPubMedGoogle Scholar
  120. 120.
    Stormorken AT, Clark N, Grindedal E, Maehle L, Møller P. Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer. Scand J Gastroenterol. 2007;42:611–7.CrossRefPubMedGoogle Scholar
  121. 121.
    Kurzawski G, Suchy J, Lener M, Klujszo-Grabowska E, Kladny J, Safranow K, et al. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet. 2006;69:40–7.CrossRefPubMedGoogle Scholar
  122. 122.
    Fidalgo P, Almeida MR, West S, Gaspar C, Maia L, Wijnen J, et al. Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach. Eur J Hum Genet. 2000;8:49–53.CrossRefPubMedGoogle Scholar
  123. 123.
    Maliaka YK, Chudina AP, Belev NF, Alday P, Bochkov NP, Buerstedde JM. CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations. Hum Genet. 1996;97:251–5.CrossRefPubMedGoogle Scholar
  124. 124.
    Buerstedde JM, Alday P, Torhorst J, Weber W, Müller H, Scott R. Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes. J Med Genet. 1995;32:909–12.CrossRefPubMedGoogle Scholar
  125. 125.
    Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105–10.CrossRefPubMedGoogle Scholar
  126. 126.
    Green SE, Chapman P, Burn J, Burt AD, Bennett M, Appleton DR, et al. Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer. Gut. 1998;43:85–92.CrossRefPubMedGoogle Scholar
  127. 127.
    Kee F, Collins BJ, Patterson CC. Prognosis in familial non-polyposis colorectal cancer. Gut. 1991;32:513–6.CrossRefPubMedGoogle Scholar
  128. 128.
    Geary J, Thomas HJ, Mackay J, Dorkins H, Barwell J, Hodgson SV. The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer. 2007;6:13–9.CrossRefPubMedGoogle Scholar
  129. 129.
    Maul JS, Warner NR, Kuwada SK, Burt RW, Cannon-Albright LA. Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol. 2006;101:1591–6.CrossRefPubMedGoogle Scholar
  130. 130.
    Fullerton DA, López F, Rahmer A. Hereditary nonpolyposis colorectal cancer: surgical treatment and pedigree analysis. Rev Med Chil. 2004;132:539–47.PubMedGoogle Scholar
  131. 131.
    Goldberg PA, Madden MV, Harocopos C, Felix R, Westbrook C, Ramesar RS. In a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary nonpolyposis colorectal cancer. Dis Colon Rectum. 1998;41:1250–3.CrossRefPubMedGoogle Scholar
  132. 132.
    Figer A, Kaplan A, Geva R, Flex D, Yaron M, Levy T, et al. Mutational analysis of the hMSH6 gene in familial and early-onset colorectal and endometrial cancer in Israeli patients. Genet Test. 2002;6:323–6.CrossRefPubMedGoogle Scholar
  133. 133.
    Fisher G, Armstron B. Familial colorectal cancer and the screening of family members. Med J Aust. 1989;150:22–5.PubMedGoogle Scholar
  134. 134.
    Shin YK, Heo SC, Shin JH, Hong SH, Ku JL, Yoo BC, et al. Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families. Hum Mutat. 2004;24:351.CrossRefPubMedGoogle Scholar
  135. 135.
    Planck M, Koul A, Fernebro E, Borg A, Kristoffersson U, Olsson H, et al. hMLH1, hMSH2, and hMSH6 mutations in hereditary nonpolyposis colorectal cancer families from southern Sweden. Int J Cancer. 1999;83:197–202.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Surgical GastroenterologyHvidovre University HospitalHvidovreDenmark

Personalised recommendations